LINC02305

Across TCGA pan-cancer cohorts, LINC02305 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated LINC02305 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC02305 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02305 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

BLCA, UCS, and STAD are the cancer types where LINC02305 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.097	0.688	<.001	90	view →
UCS	OS	Tertile	II,III,IV	0.001	0.616	<.001	72	view →
STAD	OS	Tertile	II,III,IV	0.407	0.727	.014	42	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	18	view →
KIRC	DFS	Tertile	IV	0.221	0.603	.046	18	view →
THYM	DFS	Tertile	II,III,IV	0.172	0.747	.005	18	view →
PCPG	DFS	Tertile	All	0.070	0.936	<.001	18	view →
ESCA	DFS	Tertile	III,IV	0.813	0.274	.032	12	view →
SKCM	DFS	Tertile	IV	0.040	0.432	.038	9	view →
LIHC	DFS	Tertile	All	0.209	0.450	.032	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

LINC02305–BLCA (OS)

Open the BLCA breakdown →